Standard BioTools

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LAB and other ETFs, options, and stocks.

About LAB

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. 

CEO
Michael Egholm
CEOMichael Egholm
Employees
818
Employees818
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1999
Founded1999
Employees
818
Employees818

LAB Key Statistics

Market cap
599.92M
Market cap599.92M
Price-Earnings ratio
-4.61
Price-Earnings ratio-4.61
Dividend yield
Dividend yield
Average volume
1.94M
Average volume1.94M
High today
$1.61
High today$1.61
Low today
$1.55
Low today$1.55
Open price
$1.58
Open price$1.58
Volume
897.47K
Volume897.47K
52 Week high
$1.89
52 Week high$1.89
52 Week low
$0.92
52 Week low$0.92

Stock Snapshot

As of today, Standard BioTools(LAB) shares are valued at $1.56. The company's market cap stands at 599.92M, with a P/E ratio of -4.61.

On 2026-01-19, Standard BioTools(LAB) stock moved within a range of $1.55 to $1.61. With shares now at $1.56, the stock is trading +0.6% above its intraday low and -3.1% below the session's peak.

Trading volume for Standard BioTools(LAB) stock has reached 897.47K, versus its average volume of 1.94M.

Over the past 52 weeks, Standard BioTools(LAB) stock has traded between a high of $1.89 and a low of $0.92.

Over the past 52 weeks, Standard BioTools(LAB) stock has traded between a high of $1.89 and a low of $0.92.

People also own

Based on the portfolios of people who own LAB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .